Literature DB >> 3467115

Elevated levels of p53 antigen in cultured skin fibroblasts from patients with hereditary adenocarcinoma of the colon and rectum and its relevance to oncogenic mechanisms.

L Kopelovich, A B DeLeo.   

Abstract

Skin fibroblasts (SFs) from patients with adenomatosis of the colon and rectum (ACR) were shown, in general, to express elevated amounts of the p53 antigen as determined by immunoprecipitation with the monoclonal antibody PAb421. Infection with simian virus 40 (SV40) induced expression of the p53 antigen in SFs from normal individuals and further amplified its expression in ACR cells. The half-lives of the p53 antigen in mock-infected ACR cells and in SV40-transformed normal or ACR cells were about 2 and 15 hours, respectively. No immediate differences were detected in the coding segment of the human p53 gene between normal and ACR cells by either Southern or Northern blot analysis. These results suggest that over-expression of the p53 antigen is due, in part, to the increased stability of the p53 antigen in ACR cells. Over-expression represents an early event that is possibly associated with initiation and promotion of inherited colon cancer.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3467115

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  9 in total

1.  Preclinical colorectal cancer chemopreventive efficacy and p53-modulating activity of 3',4',5'-trimethoxyflavonol, a quercetin analogue.

Authors:  Lynne M Howells; Robert G Britton; Marco Mazzoletti; Peter Greaves; Massimo Broggini; Karen Brown; William P Steward; Andreas J Gescher; Stewart Sale
Journal:  Cancer Prev Res (Phila)       Date:  2010-07-13

2.  p53 mutations in colorectal cancer.

Authors:  N R Rodrigues; A Rowan; M E Smith; I B Kerr; W F Bodmer; J V Gannon; D P Lane
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

3.  Suppression of familial adenomatous polyposis by CP-31398, a TP53 modulator, in APCmin/+ mice.

Authors:  Chinthalapally V Rao; Malisetty V Swamy; Jagan M R Patlolla; Levy Kopelovich
Journal:  Cancer Res       Date:  2008-09-15       Impact factor: 12.701

4.  Inhibition of azoxymethane-induced colorectal cancer by CP-31398, a TP53 modulator, alone or in combination with low doses of celecoxib in male F344 rats.

Authors:  Chinthalapally V Rao; Vernon E Steele; Malisetty V Swamy; Jagan M R Patlolla; Suresh Guruswamy; Levy Kopelovich
Journal:  Cancer Res       Date:  2009-10-13       Impact factor: 12.701

5.  Comparison of radiation-induced chromosomal damage between normal individuals and patients with familial polyposis coli.

Authors:  S Kakati; L Herrera; R E Drury; A A Sandberg
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

Review 6.  Current status of tumor markers in large bowel cancer.

Authors:  M Moore; D J Jones; P F Schofield; D G Harnden
Journal:  World J Surg       Date:  1989 Jan-Feb       Impact factor: 3.352

7.  A molecular signature of normal breast epithelial and stromal cells from Li-Fraumeni syndrome mutation carriers.

Authors:  Brittney-Shea Herbert; Rebecca A Chanoux; Yunlong Liu; Peter H Baenziger; Chirayu P Goswami; Jeanette N McClintick; Howard J Edenberg; Robert E Pennington; Steven M Lipkin; Levy Kopelovich
Journal:  Oncotarget       Date:  2010-10

8.  APC +/- alters colonic fibroblast proteome in FAP.

Authors:  Bhavinkumar B Patel; Xin-Ming Li; Maketa P Dixon; Elena L Blagoi; Emmanuelle Nicolas; Steven H Seeholzer; David Cheng; Yin A He; Renata A Coudry; Sharon D Howard; Dawn M Riddle; Harry C Cooper; Bruce M Boman; Peggy Conrad; James A Crowell; Alfonso Bellacosa; Alfred Knudson; Anthony T Yeung; Levy Kopelovich
Journal:  Oncotarget       Date:  2011-03

9.  Targeting cancer stem cells with p53 modulators.

Authors:  Zhan Zhang; Ling Liu; Roberto Gomez-Casal; Xinhui Wang; Ryo Hayashi; Ettore Appella; Levy Kopelovich; Albert B DeLeo
Journal:  Oncotarget       Date:  2016-07-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.